行情

AXDX

AXDX

Accelr科技
NASDAQ

实时行情|Nasdaq Last Sale

7.49
-0.07
-0.93%
休市 16:00 04/03 EDT
开盘
7.56
昨收
7.56
最高
7.93
最低
7.32
成交量
34.69万
成交额
--
52周最高
24.00
52周最低
4.530
市值
4.26亿
市盈率(TTM)
-4.8423
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测AXDX价格均价为15.00,最高价位16.00,最低价为14.00。

EPS

AXDX 新闻

更多
  • Insiders Who Are Calling A Bottom In Their Stock - Weekly Update (03/27/20 - 04/03/20)
  • Seeking Alpha - Article · 11小时前
  • Daily Insider Ratings Round Up 3/31/20
  • Seeking Alpha - Article · 2天前
  • 3 Stocks Insiders Are Snapping Up
  • TipRanks · 3天前
  • Daily Insider Ratings Round-Up 3/30/20.
  • Seeking Alpha - Article · 3天前

所属板块

先进医疗设备和技术
-1.50%
医疗设备和用品
-1.17%

热门股票

代码
价格
涨跌幅

AXDX 简况

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit.
展开

微牛提供Accelerate Diagnostics Inc(NASDAQ-AXDX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的AXDX股票新闻,以帮助您做出投资决策。